TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Zou, W. PY - 2005 DA - 2005// TI - Immunosuppressive networks in the tumour environment and their therapeutic relevance JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1586 DO - 10.1038/nrc1586 ID - Zou2005 ER - TY - JOUR AU - Singh, P. P. AU - Sharma, P. K. AU - Krishnan, G. AU - Lockhart, A. C. PY - 2015 DA - 2015// TI - Immune checkpoints and immunotherapy for colorectal cancer JO - Gastroenterol Rep VL - 3 ID - Singh2015 ER - TY - JOUR AU - Kalyan, A. AU - Kircher, S. AU - Shah, H. AU - Mulcahy, M. AU - Benson, A. PY - 2018 DA - 2018// TI - Updates on immunotherapy for colorectal cancer JO - J Gastrointest Oncol VL - 9 UR - https://doi.org/10.21037/jgo.2018.01.17 DO - 10.21037/jgo.2018.01.17 ID - Kalyan2018 ER - TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2017 DA - 2017// TI - Elements of cancer immunity and the cancer-immune set point JO - Nature. VL - 541 UR - https://doi.org/10.1038/nature21349 DO - 10.1038/nature21349 ID - Chen2017 ER - TY - JOUR AU - Ciorba, M. A. PY - 2013 DA - 2013// TI - Indoleamine 2,3 dioxygenase in intestinal disease JO - Curr Opin Gastroenterol VL - 29 UR - https://doi.org/10.1097/MOG.0b013e32835c9cb3 DO - 10.1097/MOG.0b013e32835c9cb3 ID - Ciorba2013 ER - TY - JOUR AU - Mushtaq, M. U. AU - Papadas, A. AU - Pagenkopf, A. AU - Flietner, E. AU - Morrow, Z. AU - Chaudhary, S. G. PY - 2018 DA - 2018// TI - Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers JO - J Immunother Cancer VL - 6 UR - https://doi.org/10.1186/s40425-018-0376-0 DO - 10.1186/s40425-018-0376-0 ID - Mushtaq2018 ER - TY - JOUR AU - Munn, D. H. AU - Mellor, A. L. PY - 2007 DA - 2007// TI - Indoleamine 2,3-dioxygenase and tumor-induced tolerance JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/JCI31178 DO - 10.1172/JCI31178 ID - Munn2007 ER - TY - JOUR AU - Munn, D. H. AU - Mellor, A. L. PY - 2016 DA - 2016// TI - IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance JO - Trends Immunol VL - 37 UR - https://doi.org/10.1016/j.it.2016.01.002 DO - 10.1016/j.it.2016.01.002 ID - Munn2016 ER - TY - JOUR AU - Gavin, P. D. AU - Allen, T. B. AU - Hiroaki, I. AU - Lloyd, J. O. AU - Robert, D. S. PY - 2002 DA - 2002// TI - Cancer immunoediting: from immuno- surveillance to tumor escape JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni1102-991 DO - 10.1038/ni1102-991 ID - Gavin2002 ER - TY - JOUR AU - Brandacher, G. AU - Perathoner, A. AU - Ladurner, R. AU - Schneeberger, S. AU - Obrist, P. AU - Winkler, C. PY - 2006 DA - 2006// TI - Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1966 DO - 10.1158/1078-0432.CCR-05-1966 ID - Brandacher2006 ER - TY - JOUR AU - Ferdinande, L. AU - Decaestecker, C. AU - Verset, L. AU - Mathieu, A. AU - Moles Lopez, X. AU - Negulescu, A. M. PY - 2012 DA - 2012// TI - Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer JO - Br J Cancer VL - 106 UR - https://doi.org/10.1038/bjc.2011.513 DO - 10.1038/bjc.2011.513 ID - Ferdinande2012 ER - TY - JOUR AU - Tascon, R. E. AU - Stavropoulos, E. AU - Lukacs, K. V. AU - Colston, M. J. PY - 1998 DA - 1998// TI - Protection against mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon JO - Infect Immun VL - 66 ID - Tascon1998 ER - TY - JOUR AU - Spranger, S. AU - Spaapen, R. M. AU - Zha, Y. AU - Williams, J. AU - Meng, Y. AU - Ha, T. T. PY - 2013 DA - 2013// TI - Up-Regulation of PD-L1, IDO, and T-regs in the Melanoma Tumor Microenvironment Is Driven by CD8(+) T Cells JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3006504 DO - 10.1126/scitranslmed.3006504 ID - Spranger2013 ER - TY - JOUR AU - Kloosterman, W. P. AU - Plasterk, R. H. PY - 2006 DA - 2006// TI - The diverse functions of microRNAs in animal development and disease JO - Dev Cell VL - 11 UR - https://doi.org/10.1016/j.devcel.2006.09.009 DO - 10.1016/j.devcel.2006.09.009 ID - Kloosterman2006 ER - TY - JOUR AU - Shen, Z. AU - Zhou, R. AU - Liu, C. AU - Wang, Y. AU - Zhan, W. AU - Shao, Z. PY - 2017 DA - 2017// TI - MicroRNA-105 is involved in TNF-alpha-related tumor microenvironment enhanced colorectal cancer progression JO - Cell Death Dis VL - 8 UR - https://doi.org/10.1038/s41419-017-0048-x DO - 10.1038/s41419-017-0048-x ID - Shen2017 ER - TY - JOUR AU - Zhou, X. R. AU - Mao, Y. AU - Zhu, J. J. AU - Meng, F. Y. AU - Chen, Q. AU - Tao, L. H. PY - 2016 DA - 2016// TI - TGF-beta 1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.11950 DO - 10.18632/oncotarget.11950 ID - Zhou2016 ER - TY - JOUR AU - Khorrami, S. a. m. a. n. e. h. AU - Zavaran Hosseini, A. h. m. a. d. AU - Mowla, S. e. y. e. d. J. a. v. a. d. AU - Soleimani, M. a. s. o. u. d. AU - Rakhshani, N. a. s. e. r. AU - Malekzadeh, R. e. z. a. PY - 2017 DA - 2017// TI - MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells JO - Tumor Biology VL - 39 UR - https://doi.org/10.1177/1010428317698365 DO - 10.1177/1010428317698365 ID - Khorrami2017 ER - TY - JOUR AU - Huang, Q. AU - Xia, J. J. AU - Wang, L. AU - Wang, X. AU - Ma, X. D. AU - Deng, Q. P. PY - 2018 DA - 2018// TI - miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0600-x DO - 10.1186/s13045-018-0600-x ID - Huang2018 ER - TY - JOUR AU - Uyttenhove, C. AU - Pilotte, L. AU - Theate, I. AU - Stroobant, V. AU - Colau, D. AU - Parmentier, N. PY - 2003 DA - 2003// TI - Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm934 DO - 10.1038/nm934 ID - Uyttenhove2003 ER - TY - JOUR AU - Zhao, X. S. AU - Wang, Y. N. AU - Meng-LV, Y. -. K. AU - Luo, H. X. AU - Ye, X. Y. PY - 2016 DA - 2016// TI - miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine-2,3-dioxygenase JO - Oncotarget. VL - 7 ID - Zhao2016 ER - TY - JOUR AU - Pei, X. AU - Wang, X. AU - Li, H. PY - 2018 DA - 2018// TI - LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO JO - Int J Biol Macromol VL - 118 UR - https://doi.org/10.1016/j.ijbiomac.2018.06.033 DO - 10.1016/j.ijbiomac.2018.06.033 ID - Pei2018 ER - TY - JOUR AU - Liang, C. C. AU - Park, A. Y. AU - Guan, J. L. PY - 2007 DA - 2007// TI - In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro JO - Nat Protoc VL - 2 UR - https://doi.org/10.1038/nprot.2007.30 DO - 10.1038/nprot.2007.30 ID - Liang2007 ER - TY - JOUR AU - Mónica, R. D. AU - Miguel, A. AU - Daniel, S. AU - Mario, Q. A. AU - Humberto, O. Z. AU - María, J. PY - 2015 DA - 2015// TI - MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value JO - Am J Cancer Res VL - 5 ID - Mónica2015 ER - TY - JOUR AU - Cao, Y. AU - Sonveaux, P. AU - Liu, S. AU - Zhao, Y. AU - Mi, J. AU - Clary, B. M. PY - 2007 DA - 2007// TI - Systemic overexpression of angiopoietin-2 promotes tumor microvessel regression and inhibits angiogenesis and tumor growth JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4056 DO - 10.1158/0008-5472.CAN-06-4056 ID - Cao2007 ER - TY - JOUR AU - Kausch, I. AU - Lingnau, A. AU - Endl, E. AU - Sellmann, K. AU - Deinert, I. AU - Ratliff, T. L. PY - 2003 DA - 2003// TI - Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo JO - Int J Cancer VL - 105 UR - https://doi.org/10.1002/ijc.11111 DO - 10.1002/ijc.11111 ID - Kausch2003 ER - TY - JOUR AU - Tsai, N. M. AU - Lin, S. Z. AU - Lee, C. C. AU - Chen, S. P. AU - Su, H. C. AU - Chang, W. L. PY - 2005 DA - 2005// TI - The antitumor effects of engelicasinensis on malignant brain tumors in vitro and in vivo JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1827 DO - 10.1158/1078-0432.CCR-04-1827 ID - Tsai2005 ER - TY - JOUR AU - Yoshida, N. AU - Ino, K. AU - Ishida, Y. AU - Kajiyama, H. AU - Yamamoto, E. AU - Shibata, K. PY - 2008 DA - 2008// TI - Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0991 DO - 10.1158/1078-0432.CCR-08-0991 ID - Yoshida2008 ER - TY - JOUR AU - Steven, A. R. PY - 2001 DA - 2001// TI - Progress in human tumour immunology and immunotherapy JO - Nature. VL - 411 UR - https://doi.org/10.1038/35077246 DO - 10.1038/35077246 ID - Steven2001 ER - TY - JOUR AU - Thaker, A. I. AU - Rao, M. S. AU - Bishnupuri, K. S. AU - Kerr, T. A. AU - Foster, L. AU - Marinshaw, J. M. PY - 2013 DA - 2013// TI - IDO1 Metabolites Activate beta-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice JO - Gastroenterology VL - 145 UR - https://doi.org/10.1053/j.gastro.2013.05.002 DO - 10.1053/j.gastro.2013.05.002 ID - Thaker2013 ER - TY - JOUR AU - Theate, I. AU - van Baren, N. AU - Pilotte, L. AU - Moulin, P. AU - Larrieu, P. AU - Renauld, J. -. C. AU - Herve, C. AU - Gutierrez-Roelens, I. AU - Marbaix, E. AU - Sempoux, C. AU - Van den Eynde, B. J. PY - 2014 DA - 2014// TI - Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues JO - Cancer Immunology Research VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-14-0137 DO - 10.1158/2326-6066.CIR-14-0137 ID - Theate2014 ER - TY - JOUR AU - Stocher, M. PY - 2004 DA - 2004// TI - Internal control DNA for PCR assays introduced into lambda phage particles exhibits nuclease resistance JO - Clin Chem VL - 50 UR - https://doi.org/10.1373/clinchem.2004.035519 DO - 10.1373/clinchem.2004.035519 ID - Stocher2004 ER - TY - JOUR AU - Lob, S. AU - Ebner, S. AU - Wagner, S. AU - Weinreich, J. AU - Schafer, R. AU - Konigsrainer, A. PY - 2007 DA - 2007// TI - Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses? JO - Transplantation. VL - 83 UR - https://doi.org/10.1097/01.tp.0000251646.09702.ec DO - 10.1097/01.tp.0000251646.09702.ec ID - Lob2007 ER - TY - JOUR AU - Ino, K. AU - Yamamoto, E. AU - Shibata, K. AU - Kajiyama, H. AU - Yoshida, N. AU - Terauchi, M. PY - 2008 DA - 2008// TI - Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4144 DO - 10.1158/1078-0432.CCR-07-4144 ID - Ino2008 ER - TY - JOUR AU - Baban, B. AU - Chandler, P. R. AU - Sharma, M. D. AU - Pihkala, J. AU - Koni, P. A. AU - Munn, D. H. PY - 2009 DA - 2009// TI - IDO activates regulatory T cells and blocks their conversion into Th17-like T cells JO - J Immunol VL - 183 UR - https://doi.org/10.4049/jimmunol.0900986 DO - 10.4049/jimmunol.0900986 ID - Baban2009 ER - TY - JOUR AU - Okamoto, A. AU - Nikaido, T. AU - Ochiai, K. AU - Takakura, S. AU - Saito, M. AU - Aoki, Y. PY - 2005 DA - 2005// TI - Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2671 DO - 10.1158/1078-0432.CCR-04-2671 ID - Okamoto2005 ER - TY - JOUR AU - Wainwright, D. A. AU - Balyasnikova, I. V. AU - Chang, A. L. AU - Ahmed, A. U. AU - Moon, K. S. AU - Auffinger, B. PY - 2012 DA - 2012// TI - IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-2130 DO - 10.1158/1078-0432.CCR-12-2130 ID - Wainwright2012 ER - TY - JOUR AU - Speeckaert, R. AU - Vermaelen, K. AU - Geel, N. AU - Autier, P. AU - Lambert, J. AU - Haspeslagh, M. PY - 2012 DA - 2012// TI - Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2011.09.007 DO - 10.1016/j.ejca.2011.09.007 ID - Speeckaert2012 ER - TY - JOUR AU - Mangaonkar, A. AU - Mondal, A. K. AU - Fulzule, S. AU - Pundkar, C. AU - Park, E. J. AU - Jillella, A. PY - 2017 DA - 2017// TI - A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/s41598-017-12940-0 DO - 10.1038/s41598-017-12940-0 ID - Mangaonkar2017 ER - TY - JOUR AU - Cavia-Saiz, M. AU - Rodriguez, P. M. AU - Ayala, B. AU - Garcia-Gonzalez, M. AU - Coma-del Corral, M. J. AU - Giron, C. G. PY - 2014 DA - 2014// TI - The role of plasma IDO activity as a diagnostic marker of patients with colorectal cancer JO - Mol Biol Rep VL - 41 UR - https://doi.org/10.1007/s11033-014-3080-2 DO - 10.1007/s11033-014-3080-2 ID - Cavia-Saiz2014 ER - TY - JOUR AU - Gao, Y. F. AU - Peng, R. Q. AU - Li, J. AU - Ding, Y. AU - Zhang, X. AU - Wu, X. J. PY - 2009 DA - 2009// TI - The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer JO - J Transl Med VL - 7 UR - https://doi.org/10.1186/1479-5876-7-71 DO - 10.1186/1479-5876-7-71 ID - Gao2009 ER - TY - JOUR AU - Lee, S. J. AU - Jun, S. Y. AU - Lee, I. H. AU - Kang, B. W. AU - Park, S. Y. AU - Kim, H. J. PY - 2018 DA - 2018// TI - CD274, LAG3, and IDO1 expressions in tumor-infiltrating immune cells as prognostic biomarker for patients with MSI-high colon cancer JO - J Cancer Res Clin Oncol VL - 144 UR - https://doi.org/10.1007/s00432-018-2620-x DO - 10.1007/s00432-018-2620-x ID - Lee2018 ER - TY - JOUR AU - Chen, I. C. AU - Lee, K. H. AU - Hsu, Y. H. AU - Wang, W. R. AU - Chen, C. M. AU - Cheng, Y. W. PY - 2016 DA - 2016// TI - Expression pattern and Clinicopathological relevance of the Indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase protein in colorectal Cancer JO - Dis Markers VL - 2016 ID - Chen2016 ER - TY - JOUR AU - Maggi, E. AU - Giudizi, M. G. AU - Biagiotti, R. AU - Annunziato, F. AU - Manetti, R. AU - Piccinni, M. P. PY - 1994 DA - 1994// TI - Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection JO - J Exp Med VL - 180 UR - https://doi.org/10.1084/jem.180.2.489 DO - 10.1084/jem.180.2.489 ID - Maggi1994 ER - TY - JOUR AU - Grohmann, U. AU - Fallarino, F. AU - Puccetti, P. PY - 2003 DA - 2003// TI - Tolerance, DCs and tryptophan: much ado about IDO JO - Trends Immunol VL - 24 UR - https://doi.org/10.1016/S1471-4906(03)00072-3 DO - 10.1016/S1471-4906(03)00072-3 ID - Grohmann2003 ER - TY - JOUR AU - Li, B. AU - Ge, L. AU - Li, M. H. AU - Wang, L. AU - Li, Z. H. PY - 2016 DA - 2016// TI - miR-448 suppresses proliferation and invasion by regulating IGF1R in colorectal cancer cells JO - Am J Transl Res VL - 8 ID - Li2016 ER - TY - JOUR AU - Wang, D. S. AU - Zhong, B. AU - Li, Y. AU - Liu, X. D. PY - 2016 DA - 2016// TI - miR-448 suppresses E2F3 to inhibit proliferation and induce apoptosis in human colorectal cancer cells JO - Transl Cancer Res VL - 5 UR - https://doi.org/10.21037/tcr.2016.10.46 DO - 10.21037/tcr.2016.10.46 ID - Wang2016 ER - TY - JOUR AU - Trapani, J. A. AU - Smyth, M. J. PY - 2002 DA - 2002// TI - Functional significance of the perforin/granzyme cell death pathway JO - Nat Rev Immunol VL - 2 UR - https://doi.org/10.1038/nri911 DO - 10.1038/nri911 ID - Trapani2002 ER - TY - JOUR AU - Dunn, G. P. AU - Bruce, A. T. AU - Ikeda, H. AU - Old, L. J. AU - Schreiber, R. D. PY - 2002 DA - 2002// TI - Cancer immunoediting: from immunosurveillance to tumor escape JO - Nat Immunol VL - 3 UR - https://doi.org/10.1038/ni1102-991 DO - 10.1038/ni1102-991 ID - Dunn2002 ER - TY - JOUR AU - Jérôme, G. AU - Daniela, B. PY - 2019 DA - 2019// TI - Approaches to treat immune hot, altered and cold tumours with combination immunotherapies JO - Nat Rev Drug Discov VL - 18 UR - https://doi.org/10.1038/s41573-018-0007-y DO - 10.1038/s41573-018-0007-y ID - Jérôme2019 ER -